Contributions of triggering-receptor-expressed-on-myeloid-cells-2 to neurological diseases (Q39015642)

8 September 2017

1 reference

title

Contributions of triggering-receptor-expressed-on-myeloid-cells-2 to neurological diseases (English)

1 reference

8 September 2017

Jie Han

1

1 reference

8 September 2017

Miaomiao Wang

series ordinal

2

1 reference

8 September 2017

Manru Ren

series ordinal

3

1 reference

8 September 2017

Haiyan Lou

series ordinal

4

1 reference

8 September 2017

22 November 2016

1 reference

International Journal of Neuroscience

8 September 2017

1 reference

8 September 2017

127

1 reference

8 September 2017

4

1 reference

8 September 2017

368-375

1 reference

TREMs in the immune system and beyond

8 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Heterogeneous expression of the triggering receptor expressed on myeloid cells-2 on adult murine microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Distribution and signaling of TREM2/DAP12, the receptor system mutated in human polycystic lipomembraneous osteodysplasia with sclerosing leukoencephalopathy dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

The TREM receptor family and signal integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Cloning and characterization of a novel mouse myeloid DAP12-associated receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

TREM and TREM-like receptors in inflammation and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

TREM2 in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Alzheimer's disease risk alleles in TREM2 illuminate innate immunity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

The Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

CD33 modulates TREM2: convergence of Alzheimer loci.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and beta-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

A physical interaction between the adaptor proteins DOK3 and DAP12 is required to inhibit lipopolysaccharide signaling in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

TREM2 and β-catenin regulate bone homeostasis by controlling the rate of osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

A survey of TREM2 antibodies reveals neuronal but not microglial staining in formalin-fixed paraffin-embedded postmortem Alzheimer's brain tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Late-Onset Alzheimer's Disease Genes and the Potentially Implicated Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Variant of TREM2 Associated with the Risk of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Silencing of TREM2 exacerbates tau pathology, neurodegenerative changes, and spatial learning deficits in P301S tau transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Evidence of trem2 variant associated with triple risk of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

TREM2 Variants in Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

R47H Variant of TREM2 Associated With Alzheimer Disease in a Large Late-Onset Family: Clinical, Genetic, and Neuropathological Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Evaluating pathogenic dementia variants in posterior cortical atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

TREM2 Protein Expression Changes Correlate with Alzheimer's Disease Neurodegenerative Pathologies in Post-Mortem Temporal Cortices

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Regulation of TREM2 expression by an NF-кB-sensitive miRNA-34a

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

TREM2 mRNA Expression in Leukocytes Is Increased in Alzheimer's Disease and Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Nasu-Hakola syndrome: polycystic lipomembranous osteodysplasia with sclerosing leucoencephalopathy and presenile dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Nasu-Hakola disease (polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy--PLOSL): a dementia associated with bone cystic lesions. From clinical to genetic and molecular aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

CNS manifestations of Nasu-Hakola disease: a frontal dementia with bone cysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Brain and bone damage in KARAP/DAP12 loss-of-function mice correlate with alterations in microglia and osteoclast lineages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Dap12 and Trem2, molecules involved in innate immunity and neurodegeneration, are co-expressed in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

An Italian family affected by Nasu-Hakola disease with a novel genetic mutation in the TREM2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Lipomembranous osteodysplasia: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Lipomembranous polycystic osteodysplasia (brain, bone, and fat disease): a genetic cause of presenile dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Disease-Associated Mutations of TREM2 Alter the Processing of N-Linked Oligosaccharides in the Golgi Apparatus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

New concepts in the immunopathogenesis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Drug insight: using monoclonal antibodies to treat multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

TREM2 sustains microglial expansion during aging and response to demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Analysis of the host transcriptome from demyelinating spinal cord of murine coronavirus-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Murine hepatitis virus--a model for virus-induced CNS demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Immunomodulation by transplanted human embryonic stem cell-derived oligodendroglial progenitors in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Epidemiology of neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Parkinson's disease: neurodegenerative mechanisms and neuroprotective interventions--report of a workshop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Clearance of amyloid-beta in Alzheimer's disease: shifting the action site from center to periphery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Microglial repopulation model reveals a robust homeostatic process for replacing CNS myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Novel compound heterozygous mutation in TREM2 found in a Turkish frontotemporal dementia-like family

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Homozygous TREM2 mutation in a family with atypical frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Neurodegenerative disorders and ischemic brain diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Triggering receptor expressed on myeloid cells 2 (TREM2) deficiency attenuates phagocytic activities of microglia and exacerbates ischemic damage in experimental stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Attenuated inflammatory response in triggering receptor expressed on myeloid cells 2 (TREM2) knock-out mice following stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Triggering Receptor Expressed on Myeloid Cells-2 Correlates to Hypothermic Neuroprotection in Ischemic Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

Cutting Edge: TREM-2 Attenuates Macrophage Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1264072

10.1080/00207454.2016.1264072

21 January 2018

Identifiers

DOI

1 reference

8 September 2017

1 reference